Poster Session 2: Transplant Pharmacy
Poster Abstracts
Longhorn Hall E (Exhibit Level 1) (Gaylord Texan)
Evaluation of Electrolyte Repletion and Infection Rates in Hematopoietic Cell Transplant Patients Receiving H-2 Receptor Antagonists or Proton Pump Inhibitors
Katelyn Smith, PharmD, Virginia Commonwealth University;
Mandy Gatesman, PharmD, BCOP, Virginia Commonwealth University;
May Aziz, PharmD, Virginia Commonwealth University;
William Clark, MD, MS, Virginia Commonwealth University;
Spencer Harpe, PharmD, PhD, MPH, Virginia Commonwealth University
Impact of Bone Marrow Transplant (BMT) Pharmacist (pharma) Interventions on Outcomes in Patients (pts) Undergoing Transplantation at an Academic Medical Center
Jayde Bednarik, PharmD, UMass Memorial Medical Center;
Jessica Baron, PharmD, MD Anderson;
Delila Katz, PharmD, UMass Memorial Medical Center;
Karen Smethers, PharmD, Ascension Health;
Muthalagu Ramanathan, MD, UMASS Memorial University Campus;
Jan Cerny, MD, PhD, University of Massachusetts;
Natasha Fortier, PAC, UMass Memorial Medical Center;
Lindsey Shanahan, PAC, UMass Memorial Medical Center;
Tzafra Martin, PAC, UMass Memorial Medical Center;
Laura Petrillo-Deluca, PAC, UMass Memorial Medical Center;
Rajneesh Nath, MD, UMass Memorial Medical Center
Fosaprepitant for the Prevention of Nausea and Vomiting in Patients Receiving BEAM or High-Dose Melphalan Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation
Stephen M. Clark, PharmD, Georgia Regents Medical Center;
Lindsay Schaack, PharmD Candidate, University of Georgia College of Pharmacy;
David DeRemer, PharmD, BCOP, Georgia Regents Medical Center;
Vamsi Kota, MD, Georgia Regents Medical Center;
Amber Bradley Clemmons, PharmD, BCOP, Georgia Regents Medical Center
Administration of Rabbit Anti-Thymocyte Globulin: Slowing Infusion Rate over a 4 Day Course with Aggressive Use of Pre-Medications May Decrease ATG Related Infusion Reactions
Amber Bradley Clemmons, PharmD, BCOP, Georgia Regents Medical Center;
Megan E Hartranft, PharmD, Georgia Regents Medical Center;
Vamsi Kota, MD, Georgia Regents Medical Center;
Jeremy Pantin, MD, Georgia Regents Medical Center;
Farrukh T Awan, MD, Georgia Regents Medical Center;
Huda Salman, MD, Georgia Regents Medical Center;
Anand Jillella, MD, Georgia Regents Medical Center
An Evaluation of a Pharmacokinetic Interaction Between Tacrolimus and Maraviroc in Allogeneic Stem Cell Transplant Recipients
Alex Ganetsky, PharmD, Hospital of the University of Pennsylvania;
Todd A Miano, PharmD, BCPS, Perelman School of Medicine at the University of Pennsylvania;
Mitchell E. Hughes, BS, Philadelphia College of Pharmacy;
David L. Porter, MD, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania;
Ran Reshef, MD, Blood and Marrow Transplantation Program, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
Evaluation of an Intensive Strategy to Decrease CMV Reactivation in Haploidentical Stem Cell Transplant Patients Compared to the Traditional Approach
Aimee Hammerstrom, PharmD, The University of Texas MD Anderson Cancer Center;
Lindsey Lombardi Thomas, PharmD, The University of Texas MD Anderson Cancer Center;
Alison Gulbis, PharmD, UT MD Anderson Cancer Center;
Sai Ravi Pingali, MD, UT M.D. Anderson Cancer Center;
Stefan O. Ciurea, MD, The University of Texas MD Anderson Cancer Center
Effect of Calcineurin Inhibitor Initial Dosing on Drug Levels in Pediatric Stem Cell Transplant Recipients
Monica Hente, MSN, RN, PNP-BC, CPON, St. Louis Childrens Hospital;
Rachel C Langley, Pharm D, St. Louis Children's Hospital;
Lindsay R McNeely, Pharm D candidate, St. Louis College of Pharmacy;
Savanna M Mattingly, Pharm D candidate, St. Louis College of Pharmacy
Simplified Technique for Administration of High Dose Melphalan
Donald Hutcherson, BS Pharm, Emory Healthcare/Winship Cancer Institute;
Kelly Valla, PharmD, Emory Healthcare;
Katherine Sanvidge Shah, Pharm D, Emory Healthcare;
Minal Surati, Pharm D, Emory Healthcare;
Kathy French, BS Pharm, Emory Healthcare;
Ajay Nooka, MD MPH, Emory University;
Jonathan Kaufman, MD, Emory University Winship Cancer Institute;
Sagar Lonial, MD, Emory University Winship Cancer Center;
Jonathon B Cohen, MD, Emory University Winship Cancer Institute;
Amelia Langston, MD, Emory University School of Medicine;
MaryJo Lechowicz, MD, Emory University Hospital;
Christopher Flowers, MD, Emory University;
Edmund K. Waller, MD, PhD, Emory University
Evaluation of Revised Vaccination Guideline for Hematopoietic Cell Transplant Patients in Singapore General Hospital
Yan Jiun Lim, BSc(Pharm)(Hons), M(Clin Pharm), BCOP, Singapore General Hospital;
Hong-Yen Ng, BSc(Pharm)(Hons), Singapore General Hospital;
Mui Fong Chong, B.Sc (Pharmacy), Singapore General Hospital;
Yu Ling Cheryl Lim, BSc(Pharm)(Hons), Singapore General Hospital;
Yeh Ching Linn, MD, Singapore General Hospital;
Yvonne Loh, MBBS, MRCP, FAMS, Singapore General Hospital;
Yeow Tee Goh, MD, Singapore General Hospital;
William Y K Hwang, MD, Singapore General Hospital;
Aloysius Ho, MD, Singapore General Hospital;
Sathish Gopala Krishnan, MD, Singapore General Hospital;
Francesca Lorraine Lim, MD, Singapore General Hospital
Plerixafor Mobilization in MM Patients and Impact on CD34 Cell Collection and Transplant Outcomes
Ali McBride, PharmD, MS, The University of Arizona Cancer Center;
Susan Geyer, Ph.D., The Ohio State University;
Samantha Jaglowski, MD, Ohio State University Medical Center;
Steven M. Devine, MD, Ohio State Medical Center;
Leslie A Andritsos, MD, The Ohio State University
Rapid Rituximab and Infliximab Infusions in Pediatric HSCT Patients Are Well Tolerated
Ashley Teusink, PharmD, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, Cincinnati Children's Hospital Medical Center;
Gregory Wallace, DO, Cincinnati Children's Hospital Medical Center
Safety and Efficacy of Plerixafor for Mobilization of Peripheral Blood Stem Cells in Pediatric Patients
Ashley Teusink, PharmD, Cincinnati Children's Hospital Medical Center;
Sue L Pinkard, Hoxworth Blood Center, University of Cincinnati;
Stella M. Davies, MBBS, PhD, Cincinnati Children's Hospital Medical Center;
Mark Mueller, RN, BS, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center
